This section is password-protected. Please use the group password to access the documents.
EORTC-ETOP trial opens to study pembrolizumab for patients with early stage non-small cell lung cancer 11/12/2015
DATECAN initiative publishes Guidelines for time-to-event end point definitions in breast cancer trials 19/05/2015
EORTC, through SPECTAlung, participates in EU consortium validating blood-based cancer biomarkers 29/04/2015
ETOP/EORTC trial to evaluate denosumab for treating patients with advanced non-small cell lung cancer 02/02/2015
EORTC study published in Lancet Oncology shows value of HRQOL assessment in small cell lung cancer clinical trials 28/01/2014